Mark Ragosa - CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
KNSA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Ragosa - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Share 31.1K $1.27M $40.94 Nov 12, 2025 Direct
Performance Share Unit 4.88K $264K $17.88 May 1, 2025 Direct Class A Ordinary Share
Performance Share Option 7.61K May 1, 2025 Direct Class A Ordinary Share
Restricted Share Unit 0 Sep 2, 2025 Direct Class A Ordinary Share
Share Option 0 Nov 12, 2025 Direct Class A Ordinary Share

Transactions reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.